Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kohno, K.
Right arrow Articles by Okuda, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kohno, K.
Right arrow Articles by Okuda, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2000) 15: 1056-1059
© 2000 European Renal Association-European Dialysis and Transplant Association


Case Reports

Minimal change nephrotic syndrome associated with rifampicin treatment

Keisuke Kohno, Yoshihiko Mizuta, Tomoyo Yoshida, Hisashi Watanabe, Hidemi Nishida, Kei Fukami, Syuuji Iida, Reiko Haramaki, Yoshifumi Wada, Osamu Tamai, Kiyoshi Tamaki, Seiya Kato1, Minoru Morimatsu1 and Seiya Okuda

Department of Internal Medicine III and 1 Department of Pathology, Kurume University School of Medicine, Fukuoka, Japan

Keywords: minimal change nephrotic syndrome; rifampicin



   Introduction
 
Rifampicin is a commonly used anti-tuberculosis agent which has been reported to have some adverse effects, including nephrotoxicity [1–9]. The most frequent form of nephrotoxicity is a syndrome consisting of acute renal failure, with tubular necrosis as pathological finding, with or without haemolysis and thrombocytopenia, generally occurring during intermittent or interrupted treatment. Other forms of nephrotoxicity are interstitial nephritis with or without mild glomerular lesions, rapidly progressive glomerulonephritis and light chain proteinuria [3]. We herein report a case of minimal change nephrotic syndrome (MCNS) after rifampicin treatment which was not associated with acute interstitial nephritis or any other glomerular lesion, followed by . . . [Full Text of this Article]



   Case
 


   Discussion
 


   Notes
 


   References
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?